CORC

在结果中检索

CORC

浏览/检索结果: 共68条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文
作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05
Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文
作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：45/0  |  提交时间：2020/01/03
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Su, Jinmei;  Li Mengtao;  Zeng, Xiaofeng
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 240 会议论文
作者:  Xu, J. -H.;  Jing, C. -D.;  Chen, X. -F.;  Wang, S.;  Zeng, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Efficacy and safety of once weekly dulaglutide monotherapy compared to glimepiride monotherapy in Chinese patients with type 2 diabetes mellitus who were oral antihyperglycemic medication naive: A post hoc analysis of a phase 3 randomized, double-blind study 会议论文
作者:  Li, Yiming;  Du, Liying;  Hou, Jianing
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN (TM) IN PATIENTS WITH CHRONIC HEART FAILURE 会议论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018-03-10
作者:  Gao, Runlin;  Zhang, Jian;  Liu, Heping;  Wang, Lina;  Pang, Xiaohua
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study 会议论文
60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018
作者:  Angelucci, Emanuele;  Li, Junmin;  Greenberg, Peter L.;  Depei, Wu;  Hou, Ming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31
A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer 会议论文
作者:  Lu, Shun;  Chang, Jianhua;  Liu, Xiaoqing;  Shi, Jianhua;  Lu, You
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer 会议论文
作者:  Lu, Shun;  Chang, Jianhua;  Liu, Xiaoqing;  Shi, Jianhua;  Lu, You
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace